# Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

Study · id `cardio:ct-nct04057300` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04057300](<https://clinicaltrials.gov/study/NCT04057300>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04057300

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1038 participants.

## Technical summary

Registry record NCT04057300. Randomized; no masking; primary purpose treatment. Start 2018-10-01 (actual); primary completion 2022-04-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1038 participants (enrolled count; ClinicalTrials.gov record NCT04057300, source copy `cardio:ctgov-nct04057300-2023-11-03`, retrieved 2026-10-26)
- Started: 2018-10-01 (actual) (ClinicalTrials.gov record NCT04057300, source copy `cardio:ctgov-nct04057300-2023-11-03`, retrieved 2026-10-26)
- Primary completion: 2022-04-01 (actual) (ClinicalTrials.gov record NCT04057300, source copy `cardio:ctgov-nct04057300-2023-11-03`, retrieved 2026-10-26)
- Completion: 2023-04-01 (actual) (ClinicalTrials.gov record NCT04057300, source copy `cardio:ctgov-nct04057300-2023-11-03`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04057300, source copy `cardio:ctgov-nct04057300-2023-11-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04057300-2023-11-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
- Acronym: TC4
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Ticagrelor 90mg
- Intervention (Drug): Clopidogrel 75mg
- Intervention (Drug): acetylsalicylic acid (ASA) 81mg
- Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
- Lead sponsor class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial (`cardio:pubmed-40164463`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f9892c990ac21a4da50829875598a158cbb5ce039e909dbeab5c5ba140b67d47
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
